Savara Inc Long-term Purchase Commitment, Amount
Savara Inc (SVRA) reported Long-term Purchase Commitment, Amount of $773.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-05-12
- Savara Inc long-term purchase commitment, amount for the quarter ending 2026-03-31 was $773.00K, a 3.50% decline year-over-year.
- Savara Inc long-term purchase commitment, amount for the quarter ending 2025-12-31 was -$30.00K.
- Savara Inc long-term purchase commitment, amount for the quarter ending 2025-09-30 was $1.00K.
- Savara Inc long-term purchase commitment, amount for the quarter ending 2025-06-30 was $15.00K.
- Savara Inc long-term purchase commitment, amount for fiscal 2025 was $787.00K, a 6.42% decline from fiscal 2024.
- Savara Inc long-term purchase commitment, amount for fiscal 2024 was $841.00K, a 54.59% decline from fiscal 2023.
- Savara Inc long-term purchase commitment, amount for fiscal 2023 was $1.85M, a 34.70% decline from fiscal 2022.
- Savara Inc long-term purchase commitment, amount for fiscal 2022 was $2.84M, a 1.05% decline from fiscal 2021.
| Period end | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|
| 2026-03-31 | $773.00K 10-Q · filed 2026-05-12 | $743.00K derived: sum of 2 quarters · filed 2026-05-12 | $744.00K derived: sum of 3 quarters · filed 2026-05-12 | $759.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$29.00K derived: sum of 2 quarters · filed 2026-03-13 | -$14.00K derived: sum of 3 quarters · filed 2026-03-13 | $787.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $16.00K derived: sum of 2 quarters · filed 2025-11-12 | $817.00K 10-Q · filed 2025-11-12 | $449.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $816.00K 10-Q · filed 2025-08-13 | $448.00K derived: sum of 3 quarters · filed 2025-08-13 | -$179.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $801.00K 10-Q · filed 2025-05-13 | $433.00K derived: sum of 2 quarters · filed 2025-05-13 | -$194.00K derived: sum of 3 quarters · filed 2025-05-13 | -$198.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | -$368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$995.00K derived: sum of 2 quarters · filed 2025-03-27 | -$999.00K derived: sum of 3 quarters · filed 2025-03-27 | $841.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | -$627.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$631.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.21M 10-Q · filed 2024-11-12 | $232.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.84M 10-Q · filed 2024-08-12 | $859.00K derived: sum of 3 quarters · filed 2024-08-12 | $846.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | $1.84M 10-Q · filed 2024-05-09 | $863.00K derived: sum of 2 quarters · filed 2024-05-09 | $850.00K derived: sum of 3 quarters · filed 2024-05-09 | $665.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | -$977.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$990.00K derived: sum of 2 quarters · filed 2024-03-07 | -$1.18M derived: sum of 3 quarters · filed 2024-03-07 | $1.85M 10-K · filed 2024-03-07 |
| 2023-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$198.00K derived: sum of 2 quarters · filed 2023-11-09 | $2.83M 10-Q · filed 2023-11-09 | $2.58M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.84M 10-Q · filed 2023-08-10 | $2.59M derived: sum of 3 quarters · filed 2023-08-10 | $2.56M derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $3.03M 10-Q · filed 2023-05-15 | $2.77M derived: sum of 2 quarters · filed 2023-05-15 | $2.74M derived: sum of 3 quarters · filed 2023-05-15 | $2.71M derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | -$254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$285.00K derived: sum of 2 quarters · filed 2023-03-30 | -$320.00K derived: sum of 3 quarters · filed 2023-03-30 | $2.84M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$66.00K derived: sum of 2 quarters · filed 2022-11-10 | $3.09M 10-Q · filed 2022-11-10 | $3.07M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.12M 10-Q · filed 2022-08-11 | $3.10M derived: sum of 3 quarters · filed 2022-08-11 | $3.08M derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | $3.16M 10-Q · filed 2022-05-11 | $3.13M derived: sum of 2 quarters · filed 2022-05-11 | $3.12M derived: sum of 3 quarters · filed 2022-05-11 | $2.83M derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$41.00K derived: sum of 2 quarters · filed 2022-03-30 | -$326.00K derived: sum of 3 quarters · filed 2022-03-30 | $2.87M 10-K · filed 2022-03-30 |
| 2021-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$303.00K derived: sum of 2 quarters · filed 2021-11-12 | $2.89M 10-Q · filed 2021-11-12 | -$146.91M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.91M 10-Q · filed 2021-08-12 | -$146.89M derived: sum of 3 quarters · filed 2021-08-12 | -$148.94M derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $3.19M 10-Q · filed 2021-05-13 | -$146.61M derived: sum of 2 quarters · filed 2021-05-13 | -$148.65M derived: sum of 3 quarters · filed 2021-05-13 | -$148.51M derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | -$149.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$151.84M derived: sum of 2 quarters · filed 2021-03-10 | -$151.70M derived: sum of 3 quarters · filed 2021-03-10 | $8.43M 10-K · filed 2021-03-10 |
| 2020-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.90M derived: sum of 2 quarters · filed 2020-11-05 | $158.23M 10-Q · filed 2020-11-05 | $158.30M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $160.27M 10-Q · filed 2020-08-06 | $160.34M derived: sum of 3 quarters · filed 2020-08-06 | $159.28M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $160.13M 10-Q · filed 2020-05-07 | $160.20M derived: sum of 2 quarters · filed 2020-05-07 | $159.13M derived: sum of 3 quarters · filed 2020-05-07 | $158.93M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$996.00K derived: sum of 2 quarters · filed 2020-03-12 | -$1.20M derived: sum of 3 quarters · filed 2020-03-12 | $11.33M 10-K · filed 2020-03-12 |
| 2019-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$1.27M derived: sum of 2 quarters · filed 2019-11-07 | $11.27M 10-Q · filed 2019-11-07 | $11.67M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | -$205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $12.33M 10-Q · filed 2019-08-08 | $12.73M derived: sum of 3 quarters · filed 2019-08-08 | $13.41M derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $12.54M 10-Q · filed 2019-05-09 | $12.94M derived: sum of 2 quarters · filed 2019-05-09 | $13.62M derived: sum of 3 quarters · filed 2019-05-09 | $13.12M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.08M derived: sum of 2 quarters · filed 2019-03-13 | $584.00K derived: sum of 3 quarters · filed 2019-03-13 | $11.81M 10-K · filed 2019-03-13 |
| 2018-09-30 | $680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $184.00K derived: sum of 2 quarters · filed 2018-11-07 | $11.41M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -$496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $10.73M 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $11.23M 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | $10.93M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |